In addition, we exploited this structural information to develop X0 as a therapeutic to disrupt pathogenic afucosylated IgG1 Fc-FcγRIIIa interactions in a mouse model of antibody-dependent enhancement of dengue virus infection. Here, FCGR3A is linked to dengue disease.